Activation of the HNRNPA2B1/<i>miR-93-5p</i>/FRMD6 axis facilitates prostate cancer progression in an m6A-dependent manner.

Activation of the HNRNPA2B1/miR-93-5p/FRMD6 axis facilitates prostate cancer progression in an m6A-dependent manner.

Sun, Menghao; Shen, Yuanhao; Jia, Gaozhen; Deng, Zheng; Shi, Fei; Jing, Yifeng; Xia, Shujie.

Afiliação

Sun M; Clinical Medical Center of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen Y; Institute of Urology, Shanghai Jiao Tong University, Shanghai, China.
Jia G; Clinical Medical Center of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Deng Z; Institute of Urology, Shanghai Jiao Tong University, Shanghai, China.
Shi F; Clinical Medical Center of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jing Y; Institute of Urology, Shanghai Jiao Tong University, Shanghai, China.
Xia S; Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

J Cancer ; 14(7): 1242-1256, 2023.

Article em En | MEDLINE | ID: mdl-37215455